Active Ingredient(s): Pafolacianine Sodium
FDA Approved: * November 29, 2021
Pharm Company: * ON TARGET LABS
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cytalux Overview

Pafolacianine, sold under the brand name Cytalux, is an optical imaging agent.[1][2][3] The most common side effects of pafolacianine include infusion-related reactions, including nausea, vomiting, abdominal pain, flushing, dyspepsia, chest discomfort, itching and hypersensitivity.[2][3] It was approved for medical use in the United States in November 2021.[2][4] Pafolacianine is a ...

Read more Cytalux Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Cytalux Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pafolacianine Sodium
  • Solution: 3.2mg/1.6ml (2mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pafolacianine Sodium or a similar ingredient: (1 result)